These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1487051)

  • 1. Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.
    FitzGerald DJ; Pastan I
    Biochem Soc Trans; 1992 Nov; 20(4):731-4. PubMed ID: 1487051
    [No Abstract]   [Full Text] [Related]  

  • 2. First immunotoxin therapy for many common solid tumors enters phase I clinical trial.
    Skolnick AA
    JAMA; 1993 Nov; 270(19):2280. PubMed ID: 8230582
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotoxin therapy for cancer.
    Pai LH; Pastan I
    JAMA; 1993 Jan; 269(1):78-81. PubMed ID: 8416411
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant immunotoxins: new therapeutic agents for cancer treatment.
    Pastan IH
    Cancer Detect Prev; 1993; 17(2):289-93. PubMed ID: 8402714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment.
    Reiter Y; Brinkmann U; Jung SH; Lee B; Kasprzyk PG; King CR; Pastan I
    J Biol Chem; 1994 Jul; 269(28):18327-31. PubMed ID: 7913461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant immunotoxins.
    Pastan I; Pai LH; Brinkmann U; FitzGerald D
    Breast Cancer Res Treat; 1996; 38(1):3-9. PubMed ID: 8825117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of cancer with recombinant immunotoxins.
    Pastan I
    Biochim Biophys Acta; 1997 Oct; 1333(2):C1-6. PubMed ID: 9395287
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant toxins.
    Kreitman RJ; Pastan I
    Adv Pharmacol; 1994; 28():193-219. PubMed ID: 8080817
    [No Abstract]   [Full Text] [Related]  

  • 9. Midwest symposium seeks therapeutic answers to global AIDS problem.
    Goldsmith MF
    JAMA; 1990 Jan; 263(3):345-6. PubMed ID: 2104639
    [No Abstract]   [Full Text] [Related]  

  • 10. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells.
    Du X; Ho M; Pastan I
    J Immunother; 2007 Sep; 30(6):607-13. PubMed ID: 17667524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
    Wang QC; Pai LH; Debinski W; FitzGerald DJ; Pastan I
    Cancer Res; 1993 Oct; 53(19):4588-94. PubMed ID: 8402632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotoxins and recombinant toxins in the treatment of solid carcinomas.
    Theuer CP; Pastan I
    Am J Surg; 1993 Sep; 166(3):284-8. PubMed ID: 8368439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer.
    Theuer CP; FitzGerald DJ; Pastan I
    J Urol; 1993 Jun; 149(6):1626-32. PubMed ID: 8501821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxins and recombinant toxins for cancer treatment.
    Pai LH; Pastan I
    Important Adv Oncol; 1994; ():3-19. PubMed ID: 8206493
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant toxins: new therapeutic agents for cancer.
    Pastan IH; Pai LH; Brinkmann U; Fitzgerald DJ
    Ann N Y Acad Sci; 1995 Jun; 758():345-54. PubMed ID: 7625703
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.
    Fischer A; Wolf I; Fuchs H; Masilamani AP; Wolf P
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33260619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas exotoxin--immunotoxins.
    FitzGerald DJ; Willingham MC; Pastan I
    Cancer Treat Res; 1988; 37():161-73. PubMed ID: 2908624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta.
    Nagai T; Tanaka M; Tsuneyoshi Y; Xu B; Michie SA; Hasui K; Hirano H; Arita K; Matsuyama T
    Cancer Immunol Immunother; 2009 Oct; 58(10):1577-86. PubMed ID: 19238383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D; Pastan I
    Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development.
    Kellner C; Bleeker WK; Lammerts van Bueren JJ; Staudinger M; Klausz K; Derer S; Glorius P; Muskulus A; de Goeij BE; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
    J Immunol Methods; 2011 Aug; 371(1-2):122-33. PubMed ID: 21756911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.